Firmenich Q3 2026 adjusted EBITDA rises 8% year on year on LFL basis to €482 million

By Public Technologies
  • DSM-Firmenich's Q3 2026 adjusted EBITDA rose 5% year-over-year to EUR 482 million; sales climbed 6% to EUR 2.37 billion.
  • The cost savings and restructuring program remained on track, while management reported supportive fourth-quarter business conditions.
  • For FY26, the group expects an adjusted EBITDA margin of around 20%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DSM-Firmenich AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611040100OMX_____CNEWS_EN_GNW1001301610_en) on November 04, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk